Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Immunocore
Biotech
Immunocore bispecific reduces HIV reservoir in early trial
Three patients saw levels of the virus controlled in their blood after treatment even after they stopped taking their antiretrovirals.
Darren Incorvaia
Mar 10, 2025 3:00pm
Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders
Jan 3, 2025 8:30am
Delfi debuts tumor-monitoring test alongside Immunocore collab
Feb 1, 2024 11:31am
Roche punts a pair of bispecifics, makes $490M bets disappear
Apr 26, 2023 6:30am
Immunocore gets FDA breakthrough nod for eye melanoma drug
Feb 19, 2021 8:45am
Immunocore IPO filing reveals kickback scheme, Immatics row
Jan 26, 2021 8:30am
